JP2020500922A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020500922A5 JP2020500922A5 JP2019531255A JP2019531255A JP2020500922A5 JP 2020500922 A5 JP2020500922 A5 JP 2020500922A5 JP 2019531255 A JP2019531255 A JP 2019531255A JP 2019531255 A JP2019531255 A JP 2019531255A JP 2020500922 A5 JP2020500922 A5 JP 2020500922A5
- Authority
- JP
- Japan
- Prior art keywords
- chemotherapeutic agent
- dose
- antitumor
- human interleukin
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022143644A JP2022171776A (ja) | 2016-12-07 | 2022-09-09 | がんの相乗的治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662430962P | 2016-12-07 | 2016-12-07 | |
| US62/430,962 | 2016-12-07 | ||
| PCT/US2017/064813 WO2018106754A1 (en) | 2016-12-07 | 2017-12-06 | Methods of synergistic treatment of cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143644A Division JP2022171776A (ja) | 2016-12-07 | 2022-09-09 | がんの相乗的治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020500922A JP2020500922A (ja) | 2020-01-16 |
| JP2020500922A5 true JP2020500922A5 (https=) | 2021-01-28 |
| JP7249279B2 JP7249279B2 (ja) | 2023-03-30 |
Family
ID=62492129
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531255A Active JP7249279B2 (ja) | 2016-12-07 | 2017-12-06 | がんの相乗的治療方法 |
| JP2022143644A Pending JP2022171776A (ja) | 2016-12-07 | 2022-09-09 | がんの相乗的治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143644A Pending JP2022171776A (ja) | 2016-12-07 | 2022-09-09 | がんの相乗的治療方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US11576936B2 (https=) |
| EP (1) | EP3550976A4 (https=) |
| JP (2) | JP7249279B2 (https=) |
| WO (1) | WO2018106754A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7249279B2 (ja) | 2016-12-07 | 2023-03-30 | サルスペラ，リミティド ライアビリティ カンパニー | がんの相乗的治療方法 |
| EP3652318A1 (en) | 2017-07-11 | 2020-05-20 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| WO2020014543A2 (en) | 2018-07-11 | 2020-01-16 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| CA3162344A1 (en) * | 2019-12-26 | 2021-07-01 | Aydin S. MORADIAN | Methods and agents for treating solid tumor cancers |
| EP3922255A1 (en) * | 2020-06-10 | 2021-12-15 | Prokarium Limited | Cancer therapy |
| AU2022404718A1 (en) | 2021-12-09 | 2024-05-30 | Prokarium Limited | Combination cancer therapy |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6190657B1 (en) | 1995-06-07 | 2001-02-20 | Yale University | Vectors for the diagnosis and treatment of solid tumors including melanoma |
| US6531164B1 (en) | 1998-12-03 | 2003-03-11 | The Crede Family Trust | Enteral pharmaceutical preparation |
| AU7856100A (en) | 1999-10-04 | 2001-05-10 | Vion Pharmaceuticals, Inc. | Methods for treating solid tumors with irradiation and bacteria |
| WO2002026819A2 (en) | 2000-09-26 | 2002-04-04 | Roger Williams Hospital | Recombinant bcg vaccines for the prevention and treatment of cancer |
| US20080107758A1 (en) | 2001-06-15 | 2008-05-08 | Cuticeuticals, Inc. | Topical steroid spray with botanic seed oils |
| WO2003063593A1 (en) | 2002-01-28 | 2003-08-07 | Vion Pharmaceuticals, Inc. | Methods for treating cancer by administering tumor-targetted bacteria and an immunomodulatory agent |
| DE10208653A1 (de) | 2002-02-28 | 2003-09-18 | Medinnova Ges Med Innovationen | Mikroorganismus als Träger von Nukleotidsequenzen kodierend für Zellantigene zur Behandlung von Tumoren |
| EP1644492B1 (en) | 2003-06-18 | 2009-01-07 | Genelux Corporation | Modified recombinant vaccinia viruses, uses thereof |
| US7897194B2 (en) | 2006-04-18 | 2011-03-01 | Botanic Oil Innovations, Inc. | Synergistic super potent antioxidant cold pressed botanic oil blends |
| US20050244375A1 (en) | 2004-04-29 | 2005-11-03 | Leonard Arnold S | Composition and method of cancer treatment |
| US20070128301A1 (en) | 2005-09-07 | 2007-06-07 | Saltzman Daniel A | Immune enhancement by seed oil and/or seed flour |
| US8221739B2 (en) | 2004-04-29 | 2012-07-17 | Botanic Oil Innovations, Inc. | Method of cancer treatment |
| EP1934349A4 (en) | 2005-08-30 | 2009-05-27 | Commw Scient Ind Res Org | BACTERIAL INTRODUCTION OF BIOLOGICALLY ACTIVE POLYPEPTIDES |
| US20070104689A1 (en) | 2005-09-27 | 2007-05-10 | Merck Patent Gmbh | Compositions and methods for treating tumors presenting survivin antigens |
| US9127284B2 (en) | 2012-05-04 | 2015-09-08 | The University Of Hong Kong | Modified bacteria and their uses thereof for the treatment of cancer or tumor |
| CN105983103B (zh) | 2015-03-17 | 2025-01-07 | 广州华津医药科技有限公司 | 基因工程菌vnp20009-m在制备预防和治疗癌症转移的药物上的应用 |
| JP7249279B2 (ja) * | 2016-12-07 | 2023-03-30 | サルスペラ，リミティド ライアビリティ カンパニー | がんの相乗的治療方法 |
-
2017
- 2017-12-06 JP JP2019531255A patent/JP7249279B2/ja active Active
- 2017-12-06 EP EP17877671.2A patent/EP3550976A4/en active Pending
- 2017-12-06 US US16/467,338 patent/US11576936B2/en active Active
- 2017-12-06 WO PCT/US2017/064813 patent/WO2018106754A1/en not_active Ceased
-
2022
- 2022-09-09 JP JP2022143644A patent/JP2022171776A/ja active Pending
-
2023
- 2023-01-26 US US18/159,934 patent/US12090179B2/en active Active
-
2024
- 2024-08-28 US US18/817,472 patent/US20240415898A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020500922A5 (https=) | ||
| CN1140272C (zh) | 抗肿瘤剂 | |
| Hande et al. | Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer | |
| JP2005008534A (ja) | 抗癌剤及び癌の治療方法 | |
| IT8922725A1 (it) | Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori | |
| MX2013013014A (es) | Metodo para el tratamiento de tumores solidos avanzados. | |
| CN102438608A (zh) | 包含ave8062和索拉非尼的抗肿瘤组合 | |
| CN109528731B (zh) | 具有协同作用治疗多发性骨髓瘤的药物组合物及其应用 | |
| KR20180125967A (ko) | 암 치료용 pic 포함 조성물 | |
| KR101245328B1 (ko) | 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신 및/또는 데커시놀 안젤레이트를 유효성분으로 하는 당귀추출물을 포함하는 항암제 조성물 | |
| KR101964169B1 (ko) | 항종양성 백금 착체를 함유하는 항종양제 및 항종양 효과 증강제 | |
| CN101568338A (zh) | 白血病治疗的新治疗用途 | |
| US20160375057A1 (en) | Therapeutic compositions and methods involving cell-permeable iron | |
| CN114302729B (zh) | 癌化学疗法支持剂及药品 | |
| CN115227690B (zh) | 土木香内酯在双表达型b细胞淋巴瘤中的应用 | |
| CN106668061B (zh) | 一种含有顺铂的抗癌药物组合物 | |
| CN104146999A (zh) | 冬凌草甲素和多烯紫杉醇减毒增效抗肿瘤药物组合物及其应用 | |
| TWI656131B (zh) | Ｎｒｆ－１蛋白質用以製備治療膀胱癌之藥物的用途 | |
| CN107519171A (zh) | 洛匹那韦减轻伊立替康毒性的医药新用途 | |
| JPH0211513A (ja) | 制癌剤 | |
| CN115581703A (zh) | 复方吉西他滨组合物及应用 | |
| Jin et al. | Grade Ⅳ myelosuppression after induction chemotherapy of TPF on oral cancer: clinical analysis of 29 cases | |
| CN107441088A (zh) | 阿扎那韦减轻伊立替康毒性的医药新用途 | |
| CONPAINING | CHEMOTHERAPY/SMALL CELL 98 | |
| Ameri et al. | Vinorelbine and docetaxel combination as the first line treatment in patients with metastatic breast cancer: results of a multi-centric phase ii trial in Iran |